The groundbreaking therapy of this peptide represents a significant development in the management of diabetes mellitus type 2. Different to existing therapies, tirzepatide impacts dual pathways – GLP-1 and the GIP https://tirzepatide-peptide157233.articlesblogger.com/64431278/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment